1 billion people are at risk of infection with leishmaniasis, a neglected disease strongly linked to poverty. There’s no single, simple cure: current treatments are complex and need to be adapted to the form of the disease and geographical region.
What is the relationship between the core principles and standards for humanitarian assistance and protection, and those of faith-motivated aid?
What are the opportunities for strategic cooperation between faith-based and secular humanitarian organizations?
How can faith or religious affiliation c...an be a barrier or asset to assistance work? Is the provision of some forms of assistance hindered by some beliefs or faith cultures and, if so, how can these barriers be overcome?
- See more at: http://atha.se/content/humanitarian-assistance-webcast-contemporary-role-faith-based-aid#sthash.pzBe6df0.dpuf
more
Leishmaniasis is among the most neglected diseases. The most common form is cutaneous leishmaniasis that forms lesions on the skin.
The only treatment available for cutaneous leishmaniasis is highly toxic. In some cases, patients have died because of the treatment, even though cutaneous leishmania...sis is not fatal.
more
How much protection does the current batch of COVID-19 vaccines provide us? Would you need a booster shot for new variants? What does science and evidence tell us about mass gatherings and the spread of COVID-19?
WHO’s Chief Scientist Dr Soumya Swaminathan explains in Science in 5 this week.
A range of learning resources for primary health care of the newborn are available
Time to wash Hands - Tutorial for Children
La mise à disposition des vaccins, des tests et des médicaments disponibles peut prendre longtemps, même en cas d’urgence sanitaire comme la COVID-19. En vue de garantir à tous un accès rapide à ces produits, l’OMS a mis au point un protocole d’utilisation d’urgence, le protocole EUL. ...Son fonctionnement est présenté ici.
more
What are the variants circulating at this time? How are variants classified as variants of interest or concern? What does this mean for the public? Dr Maria Van Kerkhove explains in Science in 5 this week.
Conversaciones en línea realizadas por Hospital Digital del Ministerio de Salud (Chile) con profesionales de salud y dirigidas a toda la ciudadanía, para abordar diversos temas relacionados con promoción de salud y prevención de enfermedades.
El objetivo es entregar recomendaciones e informaci...n útil a las personas para contribuir al empoderamiento en el autocuidado de su salud.
Invitada: Erika Duarte- Enfermera de la Asociación Chilena de Enfermeros Educadores en Diabetes
more
Disney Junior’s Doc McStuffins, a young girl who aspires to follow in her doctor mother’s footsteps and practices by treating whatever ails her toys, is joined by her “patients” in a hand washing public service announcement, developed courtesy of Disney Junior, which gently reminds young vie...wers to wash their hands with soap.
more
This campaign by Servier and the World Heart Federation builds on the success of the USE TO ACT NOW ON ANGINA campaign. In addition to raising awareness of the importance of acting now, this campaign explores some about the common, but less well-known signs of angina, and explains why it’s key to ...not only act now, but act early in angina.
more
This film explains the importance of screening, early detection and treatment of cervical cancer. This film is for use in skilled health worker training. Available in English, French, Somali and Swahili
Warum die Covid-19 RNA Impfung dein Erbgut nicht verändert und wie genau sie funktioniert. Frisch erklärt von deinem Impf-fluencer.
Produziert im Rahmen der #EUMythBusters.
Do the current batch of approved vaccines protect us from the Delta variant? What is the level of protection? If you can still get infected even after being fully vaccinated, then why should we vaccinate? WHO’s Chief Scientist Dr Soumya Swaminathan explains in Science in 5.
Microbes like bacteria, fungus and viruses are becoming resistant to medicines like antibiotics. WHO has declared antimicrobial resistance as a global health and developmental threat. How can we stop antimicrobial resistance? Dr Hanan Balkhy explains in Science in 5
Many countries are using the approach of mixing vaccine doses from different manufacturers. What do we know about the safety and efficacy of this approach? What does the evidence tell us about using a fraction of the vaccine dose ? Dr Katherine O’Brien explains in Science in 5 this week.
Closed C...aptioning is available for Science in 5 in several languages on YouTube:Spanish,Portuguese,Thai,Nepali,Maithili,BahasaandJapanese.
more